Skip to main content
Matthew Tremblay, MD, Neurology, Livingston, NJ

Matthew Aaron Tremblay MD PhD

Neurology•Livingston, NJ

Neuroimmunology/Multiple Sclerosis

Multiple Sclerosis Specialist

Join to View Full Profile

  • 200 S Orange AveSte 124ALivingston, NJ 07039

  • Phone+1 973-322-0133

  • Fax+1 860-679-0131

Dr. Tremblay is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Tremblay's Full ProfileAlready have an account?

Summary

  • I am a Neurologist specializing in Multiple Sclerosis and serve as Director of MS Research at RWJBarnabas Health since 2020.

    I received both my M.D. and Ph.D. from the Albert Einstein College of Medicine. I completed Neurology residency training at UCLA Medical Center and fellowship training at the UCSF Multiple Sclerosis Center. I served on the clinical Neurology faculty at UConn Health.

    • Meet 6 Physicians Now Seeing Patients at UConn Health - UConn Today

    Experts in multiple sclerosis, psychiatry, women's health, infectious diseases, and nephrology have joined the clinical faculty in recent months. Dr. Matthew Tr

    Profile: Dr. Matthew Tremblay

    Dr. Matthew Tremblay is a neurologist in the Department of Neurology at UConn Health. He specializes in the treatment of patients with multiple sclerosis.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Neuroimmunology & Multiple Sclerosis, 2015 - 2016
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2012 - 2015
  • Zucker School of Medicine at Hofstra/Northwell at Lenox Hill Hospital
    Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalInternship, Internal Medicine, 2011 - 2012
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicinePh.D, Department of Pathology, 2005 - 2011
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2011, MD

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2018 - 2027
  • CA State Medical License
    CA State Medical License 2013 - 2019
  • CT State Medical License
    CT State Medical License 2016 - 2019
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2016-2017
  • Augustus S. Rose Resident Teaching Award UCLA, 2015

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Neuronal c-Abl overexpression leads to neuronal loss and neuroinflammation in the mouse forebrain.  
    Schlatterer SD, Tremblay MA, Acker CM, Davies P., Journal of Alzheimer's Disease
  • Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg.  
    Tremblay MA, Acker CM, Davies P., Journal of Alzheimers Disease
  • Epilepsy and Neurogenesis.  
    Tremblay MA, Journal of Undergraduate Research - University of Rochester 2: 20-26

Books/Book Chapters

  • Deja Review: Neuroscience. 2nd Edition 
    Matthew TremblayMcGraw-Hill Medical, New YorkEdition 2,2010
  • Deja Review: Neuroscience 
    Matthew TremblayMcGraw-Hill Medical, New YorkEdition 1,2007

Abstracts/Posters

  • Co-morbid Lymphomatosis Cerebri and testicular lymphoma in a case of rapidly progressive dementia
    Tremblay MA, Ashley MJ, Vinters HV, Guo M, American Academy of Neurology, Washington, DC
  • Neurodegeneration as a consequence of expression of active c-abl in the adult mouse brain.
    Sarah D. Schlatterer, Matthew A. Tremblay, Christopher M. Acker, and Peter Davies, Ph.D, The International Conference on Alzheimer’s Disease and Related Disorders
  • Abl2 phosphorylates three tyrosine residues of microtubule-associated protein tau.
    Matthew A. Tremblay and Peter Davies, Ph.D, Society for Neuroscience Annual Meeting

Authored Content

  • Real-World Efficacy of COVID-19 Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab in People with Multiple SclerosisDecember 2023

Press Mentions

  • Expert Discusses First and Only Drug Approved for Progressive Multiple Sclerosis
    Expert Discusses First and Only Drug Approved for Progressive Multiple SclerosisMarch 31st, 2017
  • Sick Stem Cells Point to Better MS Drugs
    Sick Stem Cells Point to Better MS DrugsMarch 29th, 2017

Professional Memberships

External Links

  • UConn Healthhttp://facultydirectory.uchc.edu/profile?profileId=Tremblay-Matthew
  • UConn Healthhttp://today.uconn.edu/school-stories/meet-6-physicians-now-seeing-patients-uconn-health/

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Matthew Tremblay, Dr. Matthew Tremblay, MD, Dr. M Tremblay, Dr. Matthew Aaron Tremblay